Labeled for this condition
Medicines for heart attack and coronary artery disease
38 medicines have an FDA label indicated for heart attack and coronary artery disease; 26 are listed from generic labelers and 1 has a presentation in shortage now (FDA files, October 8, 2026).
Which medicines are labeled for heart attack and coronary artery disease?
Each label names the condition in its indications; the record shows the label's words. A list of labeled medicines is not a treatment plan.
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Metoprolol | Toprol, Kapspargo, Lopressor | 74 labelers | $0.085 per tablet 100 mg tablet | No | A presentation being discontinued | 39 |
| Atorvastatin | Lipitor, Atorvaliq | 59 labelers | $0.0228 per tablet 10 mg tablet | No | No current entry | 53 |
| Rosuvastatin | Crestor | 45 labelers | $0.0692 per tablet 40 mg tablet | No | No current entry | 13 |
| Lisinopril | Zestril, Qbrelis | 36 labelers | $0.0254 per tablet 20 mg tablet | Yes | No current entry | 28 |
| Amlodipine | Norvasc, Sdamlo, Norliqva | 42 labelers | $0.0102 per tablet 5 mg tablet | No | No current entry | 30 |
| Pravastatin | none listed | 37 labelers | $0.058 per tablet 20 mg tablet | No | No current entry | 17 |
| Enoxaparin | Lovenox | 16 labelers | $6.45 per mL 100 mg/mL syringe | Yes | No current entry | 6 |
| Simvastatin | Zocor | 27 labelers | $0.0321 per tablet 20 mg tablet | No | No current entry | 26 |
| Atenolol | Tenormin | 35 labelers | $0.0217 per tablet 25 mg tablet | No | No current entry | 4 |
| Nitroglycerin | Nitrostat, Nitro-Dur, Nitrolingual | 31 labelers | $0.127 per tablet 0.4 mg tablet sl | No | A presentation being discontinued | 13 |
| Amlodipine and atorvastatin | Caduet | 6 labelers | $1.34 per unit 10-40 mg | No | No current entry | 13 |
| Telmisartan | none listed | 28 labelers | $0.106 per tablet 20 mg tablet | Yes | No current entry | 3 |
| Lovastatin | none listed | 19 labelers | $0.0436 per tablet 20 mg tablet | No | No current entry | 4 |
| Ramipril | none listed | 17 labelers | $0.0707 per capsule 10 mg capsule | Yes | No current entry | 5 |
| Clopidogrel | Plavix | 35 labelers | $0.0472 per tablet 75 mg tablet | Yes | No current entry | 6 |
| Ticagrelor | Brilinta | 28 labelers | $0.253 per tablet 90 mg tablet | Yes | No current entry | 2 |
| Tirzepatide | Mounjaro, Zepbound | none listed | $538.68 per mL 10 mg/0.5 mL pen | Yes | No current entry | 0 |
| Rivaroxaban | Xarelto | 20 labelers | $0.650 per tablet 2.5 mg tablet | Yes | A presentation being discontinued | 1 |
| Gemfibrozil | Lopid | 27 labelers | $0.104 per tablet 600 mg tablet | Yes | A presentation being discontinued | 0 |
| Ezetimibe and simvastatin | Vytorin | 7 labelers | $0.285 per unit 10-80 mg | No | No current entry | 10 |
| Semaglutide | Wegovy, Ozempic, Rybelsus | none listed | $331.99 per mL 0.25-0.5 mg/dose (2 mg/3 mL) pen | Yes | A presentation being discontinued | 4 |
| Niacin | Niacor | 13 labelers | $0.193 per tablet 500 mg tablet | No | No current entry | 7 |
| Eptifibatide | none listed | 8 labelers | n/a | No | No current entry | 3 |
| Liraglutide | Victoza, Saxenda | 9 labelers | $31.41 per mL 2-pak 18 mg/3 mL | Yes | In shortage | 3 |
| Prasugrel | Effient | 10 labelers | $0.263 per tablet 10 mg tablet | Yes | No current entry | 5 |
| Dulaglutide | Trulicity | none listed | $487.57 per mL 0.75 mg/0.5 mL pen | Yes | No current entry | 2 |
| Tirofiban | Aggrastat | 4 labelers | n/a | No | No current entry | 2 |
| Dalteparin | Fragmin | none listed | n/a | Yes | No current entry | 0 |
| Canagliflozin and metformin | Invokamet | none listed | $9.58 per tablet 150-1,000 mg tablet | Yes | No current entry | 1 |
| Canagliflozin | Invokana | none listed | $19.13 per tablet 100 mg tablet | No | No current entry | 0 |
| Evolocumab | Repatha | none listed | $281.96 per mL 140 mg/mL sureclick | No | No current entry | 0 |
| Alirocumab | Praluent | none listed | $258.01 per mL 150 mg/mL pen | No | No current entry | 0 |
| Alteplase | Activase, Cathflo | none listed | $186.38 per vial 2 mg vial | No | A presentation being discontinued | 2 |
| Perindopril | none listed | 1 labeler | $0.495 per tablet 4 mg tablet | Yes | No current entry | 0 |
| Tenecteplase | Tnkase | none listed | n/a | No | No current entry | 0 |
| Cangrelor | Kengreal | 1 labeler | n/a | No | No current entry | 0 |
| Bempedoic acid | Nexletol | none listed | $13.81 per tablet 180 mg tablet | No | No current entry | 0 |
| Bempedoic acid and ezetimibe | Nexlizet | none listed | $13.80 per tablet 180-10 mg tablet | No | No current entry | 2 |
Source: FDA drug labels (indications) via openFDA; NDC Directory; CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)
What do pharmacies pay?
Each medicine's most widely listed form, per unit, in the NADAC survey: what pharmacies paid, not what a patient pays; strengths differ, so compare like with like.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price